Clinical trial
Clinical Effect of Thoracic Sympathetic Ganglion Block With Botulinum Toxin Type A in Patients With Upper Extremity Complex Regional Pain Syndrome: A Prospective Randomized, Double-blind, and Comparative Clinical Trial
NCT06470581 is registered in ClinicalTrials.gov with Seoul National University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Effect of Thoracic Sympathetic Ganglion Block With Botulinum Toxin Type A in Patients With Upper Extremity Complex Regional Pain Syndrome: A Prospective Randomized, Double-blind, and Comparative Clinical Trial
- Lead sponsor
- Seoul National University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- July 1, 2024
- Completion date
- April 25, 2027
- Enrollment
- 78 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.